|
Title
|
|
|
|
FOLFIRI with cetuximab or bevacizumab: FIRE-3
|
|
|
Author
|
|
|
|
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
The lancet oncology. - London
|
|
|
Publication
|
|
|
|
London
:
2014
|
|
|
ISSN
|
|
|
|
1470-2045
|
|
|
DOI
|
|
|
|
10.1016/S1470-2045(14)70401-2
|
|
|
Volume/pages
|
|
|
|
15
:13
(2014)
, p. E582-E583
|
|
|
ISI
|
|
|
|
000346912300003
|
|
|
Pubmed ID
|
|
|
|
25456374
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|